1.250 Å
X-ray
2006-10-24
Name: | Protease |
---|---|
ID: | Q7SSI0_9HIV1 |
AC: | Q7SSI0 |
Organism: | Human immunodeficiency virus 1 |
Reign: | Viruses |
TaxID: | 11676 |
EC Number: | / |
Chain Name: | Percentage of Residues within binding site |
---|---|
A | 51 % |
B | 49 % |
B-Factor: | 16.227 |
---|---|
Number of residues: | 42 |
Including | |
Standard Amino Acids: | 42 |
Non Standard Amino Acids: | 0 |
Water Molecules: | 0 |
Cofactors: | |
Metals: |
Ligandability | Volume (Å3) |
---|---|
1.047 | 901.125 |
% Hydrophobic | % Polar |
---|---|
40.07 | 59.93 |
According to VolSite |
HET Code: | ROC |
---|---|
Formula: | C38H51N6O5 |
Molecular weight: | 671.849 g/mol |
DrugBank ID: | DB01232 |
Buried Surface Area: | 65.37 % |
Polar Surface area: | 167.94 Å2 |
Number of | |
---|---|
H-Bond Acceptors: | 6 |
H-Bond Donors: | 6 |
Rings: | 5 |
Aromatic rings: | 3 |
Anionic atoms: | 0 |
Cationic atoms: | 1 |
Rule of Five Violation: | 3 |
Rotatable Bonds: | 13 |
X | Y | Z |
---|---|---|
18.3602 | 23.5447 | 18.0249 |
Represent the protein/ligand binding mode, centered on the ligand
Dashed lines represents hydrogen bonds and metal interactions
Green residue labels for amino acids with hydrophobic contacts (green lines) to the ligand
Ligand | Protein | Interaction | |||
---|---|---|---|---|---|
Atom | Atom | Residue | Distance (Å) | Angle (°) | Type |
O2 | OD1 | ASP- 25 | 2.56 | 154.93 | H-Bond (Protein Donor) |
N2 | O | GLY- 27 | 3.2 | 156.02 | H-Bond (Ligand Donor) |
O | N | ASP- 29 | 3.02 | 161.13 | H-Bond (Protein Donor) |
OD1 | N | ASP- 30 | 3.18 | 141.47 | H-Bond (Protein Donor) |
N | O | GLY- 48 | 3.04 | 135.31 | H-Bond (Ligand Donor) |
ND2 | O | GLY- 48 | 3.23 | 152.01 | H-Bond (Ligand Donor) |
C22 | CD1 | ILE- 50 | 3.6 | 0 | Hydrophobic |
C32 | CD1 | ILE- 50 | 3.67 | 0 | Hydrophobic |
CD1 | CG1 | ILE- 50 | 4.33 | 0 | Hydrophobic |
C51 | CG | PRO- 81 | 3.83 | 0 | Hydrophobic |
C41 | CG2 | VAL- 82 | 4.32 | 0 | Hydrophobic |
C71 | CG2 | VAL- 84 | 3.99 | 0 | Hydrophobic |
CD2 | CD2 | LEU- 123 | 3.69 | 0 | Hydrophobic |
O2 | OD1 | ASP- 125 | 2.96 | 120.41 | H-Bond (Ligand Donor) |
O2 | OD2 | ASP- 125 | 2.59 | 156.32 | H-Bond (Ligand Donor) |
C11 | CB | ALA- 128 | 4.21 | 0 | Hydrophobic |
C22 | CB | ALA- 128 | 4.01 | 0 | Hydrophobic |
C11 | CB | ASP- 130 | 4.21 | 0 | Hydrophobic |
C11 | CG2 | VAL- 132 | 4.11 | 0 | Hydrophobic |
C22 | CG2 | VAL- 132 | 4.02 | 0 | Hydrophobic |
C11 | CD1 | ILE- 147 | 4.49 | 0 | Hydrophobic |
C32 | CD1 | ILE- 147 | 3.88 | 0 | Hydrophobic |
CB | CD1 | ILE- 150 | 3.85 | 0 | Hydrophobic |
C61 | CB | ILE- 150 | 4.09 | 0 | Hydrophobic |
C4A | CG | PRO- 181 | 4.42 | 0 | Hydrophobic |
C6 | CB | PRO- 181 | 3.43 | 0 | Hydrophobic |
C7 | CG | PRO- 181 | 3.38 | 0 | Hydrophobic |
CZ | CG | PRO- 181 | 3.98 | 0 | Hydrophobic |
C5 | CG2 | VAL- 182 | 4.06 | 0 | Hydrophobic |
CZ | CB | VAL- 182 | 3.97 | 0 | Hydrophobic |
C22 | CG1 | VAL- 184 | 4.11 | 0 | Hydrophobic |
CG1 | CG2 | VAL- 184 | 4.05 | 0 | Hydrophobic |